Expressions of Matrix Metalloproteinases in Early-Stage Oral Squamous Cell Carcinoma as Predictive Indicators for Tumor Metastases and Prognosis

Clinical Cancer Research

Volumn 10, Issue 2, 2004, Pages 634-640

  Katayama, Akihiro ^a   Bandoh, Nobuyuki ^a   Kishibe, Kan ^a   Takahara, Miki ^a   Ogino, Takeshi ^a   Nonaka, Satoshi ^a   Harabuchi, Yasuaki ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B;

ARTICLE; ASIAN; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ANALYSIS; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DEATH; FEMALE; HUMAN; IMMUNOHISTOLOGY; JAPAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RISK FACTOR; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MIDDLE AGED; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TREATMENT OUTCOME;

EID: 0842311599     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-0864-02     Document Type: Article

References (24)

1. Liotta, L. A. Tumor invasion and metastases: role of the extracellular matrix. Rhoads Memorial Award Lecture. Cancer Res., 46: 1-7, 1986.
2. r 72, 000 type IV collagenase. Cancer Res., 52: 5845-5848, 1992.
3. Stetler-Stevenson, W. G., Aznavoorian, S., and Liotta, L. A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol., 9: 541-573, 1993.
4. Imai, K., Ohuchi, E., Aoki, T., Nomura, H., Fujii, Y., Sato, H., Seiki, M., and Okada, Y. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res., 56: 2707-2710, 1996.
5. Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A., and Goldberg, G. I. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem., 270: 5331-5338, 1995.
6. Sato, H., Takino, T., Kinoshita, T., Imai, K., Okada, Y., Stetler-Stevenson, W. G., and Seiki, M. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP). FEBS Lett., 385: 238-240, 1996.
7. Kurahara, S., Shinohara, M., Ikebe, T., Nakamura, S., Beppu, M., Hiraki, A., Takeuchi, H., and Shirasuna, K. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck, 21: 627-638, 1999.
8. Imanishi, Y., Fujii, M., Tokumaru, Y., Tomita, T., Kanke, M., Kanzaki, J., Kanayama, K., Otani, Y., and Sato, H. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma. Hum. Pathol., 31: 895-904, 2000.
9. Nakamura, H., Ueno, H., Yamashita, K., Shimada, T., Yamamoto, E., Noguchi, M., Fujimoto, N., Sato, H., Seiki, H., and Okada, Y. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Cancer Res., 59: 467-473, 1999.
10. Riedel, F., Gotte, K., Schwalb, J., Bergler, W., and Hormann, K. Expression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma. Int. J. Oncol., 17: 1099-1105, 2000.
11. O-charoenrat, P., Rhys-Evans, P. H., and Eccles, S. A. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg., 127: 813-820, 2001.
12. Kusukawa, J., Sasaguri, Y., Shima, I., Kameyama, T., and Morimatsu, M. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathologic study. Am. J. Clin. Pathol., 99: 18-23, 1993.
13. Yoshizaki, T., Maruyama, Y., Sato, H., and Furukawa, M. Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma. Int. J. Cancer, 95: 44-50, 2001.
14. Yoshizaki, T., Sato, H., Maruyama, Y., Murono, S., Furukawa, M., Park, C. S., and Seiki, M. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma. Cancer (Phila.), 79: 139-144, 1997.
15. Bandoh, N., Hayashi, T., Kishibe, K., Takahara, M., Imada, M., Nonaka, S., and Harabuchi, Y. Prognostic value of p53 mutation, bax, and spontaneous apoptosis in maxillary sinus squamous cell carcinoma. Cancer (Phila.), 94: 1968-1979, 2002.
16. Lam, E. W. N., Hammad, H. M., Zwacka, R., Oberley, T. D., and Oberley, L. W. Immunolocalization and adenoviral vector-mediated manganese superoxide dismutase gene transfer to experimental oral tumors. J. Dent. Res., 79: 1410-1417, 2000.
17. Yang, J., Lam, E. W., Hammad, H. M., Oberley, T. D., and Oberley, L. W. Antioxidant enzyme levels in oral squamous cell carcinoma and normal human oral epithelium. J. Oral Pathol. Med., 31: 71-77, 2002.
18. Huhtala, P., Tuuttila, A., Chow, L. T., Lohi, J., Keski-Oja, J., and Tryggvason, K. Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells. J. Biol. Chem., 266: 16485-16490, 1991.
19. Fujimoto, N., Hosokawa, N., Iwata, K., Shinya, T., Okada, Y., and Hayakawa, T. A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase, gelatinase B) using monoclonal antibodies. Clin. Chim. Acta, 231: 79-88, 1994.
20. Stetler-Stevenson, W. G., Krutzsch, H. C., and Liotta, L. A. Tissue inhibitor of metalloproteinase (TIMP-2). J. Biol. Chem., 264: 17374-17378, 1989.
21. Gohji, K., Fujimoto, N., Ohkawa, J., Fujii, A., and Nakajima, M. Imbalance between serum matrix metalloproteinase-2 and its inhibitor as a predictor of recurrence of urothelial cancer. Br. J. Cancer, 77: 650-655, 1998.
22. Kanayama, H., Yokota, K., Kurokawa, Y., Murakami, Y., Nishitani, M., and Kagawa, S. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer. Cancer (Phila.), 82: 1359-1366, 1998.
23. Visscher, D. W., Hoyhtya, M., Ottosen, S. K., Liang, C. M., Sarkar, F. H., Crissman, J. D., and Fridman, R. Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int. J. Cancer, 59: 339-344, 1994.
24. Kikuchi, R., Noguchi, T., Takeno, S., Kubo, N., and Uchida, Y. Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma. Br. J. Cancer, 83: 215-218, 2000.